Skip to main content

PALISADE CAPITAL MANAGEMENT, LP

Position in CSTL — Castle Biosciences Inc

CIK 1009006 FORT LEE, NJ

Position in CSTL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$13,155,952
-$8,930,573 QoQ
Shares Held
535,884
-5.6% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 52% Shared 48% None 0%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $70,717,565 across 5 Diagnostics & Research names. CSTL ranks #3 (18.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 CSTL
Castle Biosciences Inc
This page
535,884 $13,155,952

All Filings in CSTL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,155,952 535,884
2025-12-31 $22,086,525 567,777
2025-09-30 $14,542,197 638,656
2025-06-30 $11,743,868 575,116
2025-03-31 $9,809,159 489,968
2024-12-31 $13,416,729 503,442
2024-09-30 $14,326,080 502,317
2024-06-30 $11,711,693 537,974
2024-03-31 $12,119,749 547,167
2023-12-31 $11,634,533 539,135
2023-09-30 $10,172,188 602,261
2023-06-30 $8,262,238 602,204
2023-03-31 $13,109,848 577,018
2022-12-31 $12,972,776 551,095
2022-09-30 $15,124,939 579,944
2022-06-30 $12,707,579 578,933
2022-03-31 $18,358,147 409,232
2021-12-31 $15,109,145 352,441